Related by context. All words. (Click for frequent words.) 63 BRAF inhibitor 63 vemurafenib 62 regorafenib 62 EndoTAGTM 1 61 oral ridaforolimus 61 YONDELIS 61 Erbitux cetuximab 61 T DM1 61 OvaRex ® MAb 61 OvaRex 61 lapatinib Tykerb 61 pertuzumab 60 indibulin 60 enzastaurin 60 Omnitarg 60 sorafenib Nexavar 60 IMA# 60 Aplidin 60 alvespimycin 60 Amrubicin 60 Talabostat 60 sunitinib malate 60 neratinib 60 Targretin 60 L BLP# 60 iniparib 59 Cytoxan 59 trastuzumab DM1 T DM1 59 trastuzumab DM1 59 OncoVEX 59 Ceflatonin 59 MyVax R 59 ixabepilone 59 Degarelix 59 ZACTIMA 59 axitinib 59 bevacizumab Avastin 59 PDE4 inhibitor 59 Azedra 59 Vandetanib 59 MAGE A3 ASCI 59 Cloretazine 58 exemestane Aromasin 58 Gemzar gemcitabine 58 cetuximab Erbitux 58 deforolimus 58 ZOLINZA 58 radiation sensitizer 58 Treanda 58 Syncria 58 Pazopanib 58 Ophena TM 58 Vectibix panitumumab 58 Pertuzumab 58 entinostat 58 AEG# 58 Temsirolimus 58 Zolinza 58 AVASTIN 58 Nebido 58 Tarceva TM 58 Troxatyl 58 Bezielle 58 dacetuzumab 58 abiraterone 58 Theratope 58 anti EGFR antibody 58 Rituxan rituximab 58 tanespimycin 58 Arranon 58 Xelox 57 Mipomersen 57 evaluating T DM1 57 targeted radiotherapeutic 57 multi kinase inhibitor 57 Panzem 57 sorafenib tablets 57 lorvotuzumab mertansine 57 ToGA 57 elacytarabine 57 Onconase 57 metastatic hormone refractory 57 Abiraterone 57 liposomal formulation 57 immunotherapeutic vaccine 57 Lucanix R 57 Taxotere chemotherapy 57 Cloretazine ® 57 Ophena 57 Proxinium TM 57 aflibercept VEGF Trap 57 PROSTVAC TM 57 MEK inhibitors 57 galiximab 57 Tykerb lapatinib 57 Egrifta 57 Onrigin 57 bevacizumab Avastin ® 57 Nexavar ® 57 topical gel containing 57 PrevOnco ™ 57 CoFactor 57 amrubicin 57 Onco TCS 57 DCVax R 57 paclitaxel Taxol ® 57 immunotherapeutic agent 57 Herceptin trastuzumab 57 mTOR inhibitor 57 DCVax Brain 57 indolent NHL 57 Virulizin ® 57 ridaforolimus 57 Xyotax 56 HER2 positive metastatic breast 56 Annamycin 56 Campath alemtuzumab 56 EOquin 56 forodesine 56 vorinostat 56 Advexin 56 Alimta pemetrexed 56 thalidomide Thalomid 56 cangrelor 56 PSMA ADC 56 INCB# [001] 56 Genentech Herceptin 56 TOCOSOL Paclitaxel 56 oral Xeloda 56 vinflunine 56 Panzem R NCD 56 anastrozole 56 Allovectin 7 56 IMC A# 56 Velcade bortezomib 56 Vilazodone 56 SUTENT 56 MyVax 56 bortezomib Velcade 56 obatoclax 56 cediranib 56 Folotyn 56 Nanobody 56 TREANDA 56 aflibercept 56 CYC# 56 hormone agonist 56 OHR/AVR# 56 ganetespib 56 oral prodrug 56 depsipeptide 56 paclitaxel Taxol 56 Sudhir Agrawal D.Phil 56 bazedoxifene 56 SERMs 56 lintuzumab 56 Avastin bevacizumab 56 Fablyn 56 Aflibercept 56 Revlimid lenalidomide 56 aleglitazar 56 HGS# 56 Vicinium TM 56 Provenge sipuleucel T 56 anidulafungin 56 trabectedin 56 assessing T DM1 56 Neuvenge 56 chemotherapeutic regimen 56 Genasense ® 56 Rebif ® 56 Zemplar 56 trastuzumab Herceptin 56 EFAPROXYN 55 reslizumab 55 oral chemotherapeutic agent 55 rNAPc2 55 gemcitabine chemotherapy 55 atrasentan 55 vidofludimus 55 Orencia abatacept 55 HER2 positive breast cancer 55 Hycamtin 55 angiogenesis inhibitor 55 investigational compound 55 Provenge prostate cancer 55 HQK 55 Vidaza azacitidine 55 KRAS status 55 Ixempra 55 Nexavar sorafenib 55 talabostat 55 trastuzumab Herceptin ® 55 IL# PE#QQR 55 panitumumab 55 Zarnestra 55 taxane 55 Abiraterone acetate 55 ChronVac C R 55 MDV# 55 tesmilifene 55 Jevtana 55 docetaxel Taxotere ® 55 orally dosed 55 KRN# 55 vosaroxin 55 Taxol paclitaxel 55 teriflunomide 55 Maribavir 55 receptor tyrosine kinase inhibitor 55 bortezomib Velcade R 55 refractory metastatic 55 Fludara ® 55 trastuzumab emtansine T DM1 55 EOquin TM 55 pomalidomide 55 Taxotere docetaxel 55 OMP #M# 55 docetaxel Taxotere R 55 methylnaltrexone 55 metastatic kidney 55 Rilutek 55 sorafenib Nexavar ® 55 DPX Survivac 55 BAY #-# 55 EndoTAG 55 Ziopharm 55 OMP #R# 55 Votrient 55 RoActemra 55 VNP#M 55 paclitaxel Taxol R 55 pain palliation 55 OncoVEX GM CSF 55 oxaliplatin Eloxatin 55 Phase Ib II 55 metastatic colorectal 55 capecitabine Xeloda R 55 corticosteroid dexamethasone 55 Ambrisentan 55 Gleevec imatinib 54 Yervoy 54 chemotherapeutic drug 54 drug Treanda 54 gemcitabine Gemzar 54 protease inhibitor PI 54 dexpramipexole 54 Caelyx 54 RSR# 54 phase IIb clinical 54 registrational 54 HER2 + 54 cabazitaxel 54 Fibrin Pad 54 Pemetrexed 54 autologous cellular immunotherapy 54 Bevacizumab 54 figitumumab 54 Civacir 54 letrozole Femara 54 riluzole 54 lasofoxifene 54 TLR9 agonist 54 capecitabine Xeloda 54 ELACYT 54 Cabazitaxel 54 trastuzumab Herceptin R 54 abiraterone acetate 54 Omapro 54 biologic therapies 54 Telatinib 54 talactoferrin 54 nonsmall cell lung cancer 54 CANCIDAS 54 orBec 54 erlotinib Tarceva 54 proteasome inhibitors 54 oral antiviral 54 cetuximab Erbitux ® 54 luteinizing hormone releasing 54 Telavancin 54 Sanofi Aventis Taxotere 54 humanised monoclonal antibody 54 HuLuc# 54 TEMODAL 54 dalbavancin 54 Amigal 54 Orathecin 54 Romidepsin 54 Doxil 54 Acapodene 54 Urocidin 54 Xanafide 54 Leukine 54 Promacta 54 Mepact 54 imatinib Gleevec 54 ticagrelor Brilinta 54 Targretin capsules 54 dirucotide 54 GRNVAC1 54 Pixantrone 54 KRAS mutations occur 54 standard chemotherapy regimen 54 5 fluorouracil leucovorin 54 Erlotinib 54 ponatinib 54 Zemplar Capsules 54 pralatrexate 54 XmAb# 54 huC# DM4 54 PLK1 SNALP 54 Sensipar 54 FOLOTYN 54 integrase inhibitor 54 Mylotarg 54 Afatinib 54 Actemra 54 AA amyloidosis 54 Tolamba 54 Factor VIIa 54 GW# [003] 54 Intravenous CP 54 sapacitabine 54 Vectibix 54 Certican 54 zalutumumab 54 alkylating agent 54 Celgene Revlimid 54 microtubule inhibitor 54 Reverset 54 docetaxel Taxotere 54 metastatic castrate resistant 54 IRX 2 54 HCV protease inhibitor 54 orally bioavailable 54 targeted antifolate 54 Replagal 54 R sorafenib tablets 54 StemEx R 54 Zadaxin 54 Bevacizumab Avastin 54 biologic therapy 54 Alimta 54 BRIM2 54 mertansine 54 PROVENGE sipuleucel T 53 ATL# [001] 53 Xeloda capecitabine 53 Dendreon Provenge 53 GVAX 53 PrevOnco 53 PXD# 53 perifosine 53 Amplimexon 53 Asentar 53 PRT# 53 Corlux 53 IMC #B 53 MOZOBIL 53 liprotamase 53 chemotherapy FOLFOX 53 Xcellerated T Cells 53 clofarabine 53 temsirolimus 53 drug figitumumab 53 HuMax CD# 53 Avastin 53 PARP inhibitor 53 elotuzumab 53 Leukine ® 53 relapsed MM 53 bendamustine 53 relapsing remitting multiple sclerosis 53 Removab 53 lapatinib 53 Afresa 53 docetaxel chemotherapy 53 Myocet 53 AAG geldanamycin analog 53 HERCEPTIN 53 mapatumumab 53 pharmacodynamic properties 53 phenoxodiol 53 LHRH antagonist 53 monoclonal antibody therapies 53 novel peptide 53 Combidex 53 relapsed leukemia 53 Teysuno 53 palifosfamide 53 LEP ETU 53 LY# [002] 53 Ethyol 53 Fodosine 53 CCR5 inhibitor 53 Marqibo 53 Insegia 53 Pralatrexate 53 tasocitinib 53 relapsed SCLC 53 MYDICAR ® 53 cladribine 53 Intuniv 53 Dapagliflozin 53 ISENTRESS 53 TRISENOX 53 investigational humanized monoclonal antibody 53 baminercept 53 tecarfarin 53 INTELENCE 53 PLX# 53 solanezumab 53 oral antidiabetic 53 goserelin 53 Sebivo 53 belinostat 53 HuMax EGFr 53 nucleoside analog 53 Panzem R 53 histone deacetylase HDAC inhibitor 53 BEXXAR 53 mCRC patients 53 ASA# 53 tremelimumab 53 MGd 53 oral anticancer 53 roflumilast 53 Torisel 53 Temodar ® 53 thymalfasin 53 Relovair 53 Femara letrozole 53 RhuDex ® 53 hormone refractory metastatic prostate 53 Shark cartilage 53 alpha interferon 53 anti angiogenic therapy 53 DEB# 53 TheraSphere 53 metastatic pancreatic 53 Nuedexta 53 Novartis Gleevec 53 ambrisentan 53 anticancer agent 53 Avastin Tarceva 53 Aromasin 53 malignant pleural mesothelioma 53 Prostate AdenoCarcinoma Treatment 53 dasatinib Sprycel 53 relapsed ovarian cancer 53 rhThrombin 53 tolevamer 53 adalimumab Humira 53 hormone LHRH antagonist 53 OncoVex 53 proteasome inhibitor 53 LY# [003] 53 superficial bladder cancer 53 IGF 1R inhibitor 53 tafamidis 53 Lapatinib 53 anti leukemic 53 pegylated liposomal doxorubicin 53 GRN#L 53 riociguat 53 Trexima 53 Atrasentan 53 Tarceva erlotinib 53 eniluracil 53 HuMax CD4 53 HGS ETR2 53 registrational trial 53 FASLODEX 53 bosutinib 52 Tracleer 52 Velcade 52 lumiliximab 52 Faslodex 52 Arcalyst 52 alefacept 52 LymphoStat B 52 DCVax 52 picoplatin 52 MGCD# [001] 52 sipuleucel T 52 Romiplostim 52 GALNS 52 Phenoptin 52 Tocosol 52 Vivaglobin 52 HRPC 52 Quinamed 52 Sutent sunitinib 52 fluoroquinolone antibiotic 52 Alzhemed 52 Dasatinib 52 Filgrastim 52 ThermoDox 52 chemotherapeutic agent 52 Onsolis 52 LHRH receptor positive 52 MabThera rituximab 52 Fusilev 52 selective orally bioavailable 52 StaphVAX 52 cabozantinib 52 JAK inhibitors 52 Abraxane 52 Raptiva ® 52 xanthine oxidase inhibitor 52 Tarceva 52 investigational protease inhibitor 52 chemotherapy cisplatin 52 #I TM# 52 erlotinib Tarceva ® 52 olaparib 52 opioid induced constipation OIC 52 IRESSA 52 Menerba 52 MNTX 52 DCVax R Brain 52 KRAS mutation 52 ADVEXIN 52 metastatic castration resistant 52 Adjuvant chemotherapy 52 Axitinib 52 Simponi golimumab 52 Exforge HCT 52 BioVant 52 Genentech Rituxan 52 Pulminiq 52 Tocosol Paclitaxel 52 Factor Xa inhibitor 52 Gleevec imatinib mesylate 52 Relistor 52 Hepatocellular Carcinoma HCC 52 castration resistant prostate cancer 52 Dabigatran 52 personalized immunotherapy 52 metastatic HRPC 52 Junovan 52 infliximab Remicade 52 recurrent ovarian cancer 52 IIa trial 52 Trastuzumab 52 midstage studies 52 relapsed multiple myeloma 52 Ranexa 52 refractory prostate cancer 52 Ceplene/IL-2 52 Cetuximab Erbitux 52 taxane chemotherapy 52 Orazol 52 Herceptin 52 Crizotinib 52 cilengitide 52 ORENCIA R 52 gemcitabine carboplatin 52 Sorafenib Nexavar 52 Allovectin 7 ® 52 Azacitidine 52 PEGylated interferon 52 tigecycline 52 ONCONASE 52 recurrent glioma 52 ELOXATIN 52 Angiolix 52 antitumor effect 52 recurrent metastatic 52 intranasal delivery 52 Trabectedin 52 levosimendan 52 satraplatin 52 Dacogen injection 52 Roche Xeloda 52 Riluzole 52 refractory metastatic colorectal cancer 52 nonsquamous 52 pazopanib 52 hormone refractory prostate cancer 52 Elvitegravir 52 Ipilimumab 52 Eliquis 52 active cellular immunotherapy 52 Tygacil 52 Maraviroc 52 inecalcitol 52 Gemzar 52 Firazyr 52 evaluating tivozanib 52 Platinol 52 gefitinib Iressa 52 Diamyd ® 52 Treximet 52 etanercept Enbrel 52 prodrug 52 HER2 positive 52 topical formulations 52 anti androgen 52 rituximab Rituxan 51 amphotericin B 51 CBLC# 51 ProLindac 51 relapsing multiple sclerosis 51 recurrent glioblastoma multiforme 51 Ontak 51 Interferon alfa 51 Novantrone 51 UCB Cimzia 51 PTK ZK 51 antibody MAb 51 Canvaxin 51 Arzerra 51 Pegintron 51 JVRS 51 molecularly targeted 51 azacytidine 51 FTY# 51 Selzentry 51 cutaneous T cell 51 Humira adalimumab 51 TTF Therapy 51 pancreatic NET 51 tyrosine kinase inhibitor 51 motesanib 51 Irinotecan 51 Pixuvri 51 HepaGam B 51 Halaven 51 CCR5 antagonists 51 IMP# 51 NXL# 51 PARP inhibitors 51 Tykerb 51 panitumumab Vectibix 51 anticancer therapy 51 subcutaneous formulation 51 prostate cancer CRPC 51 oral anticoagulant 51 prostate cancer HRPC 51 fulvestrant 51 low dose cytarabine 51 efalizumab 51 Erbitux 51 Aptivus 51 Vertex hepatitis C 51 Zytiga 51 VitiGam 51 LAF# 51 Telcyta 51 cancer immunotherapies 51 Merck KGaA Erbitux 51 ONTAK 51 VPRIV 51 LEUKINE 51 Increlex R 51 metastatic colorectal cancer 51 Enbrel etanercept 51 tipifarnib 51 PROCHYMAL 51 Satraplatin 51 TNFerade 51 PI3K inhibitor 51 metastatic sarcoma 51 Roche Herceptin 51 hormone LHRH agonist 51 DPP4 inhibitor 51 samalizumab 51 Gefitinib 51 advanced metastatic prostate 51 fingolimod 51 Aurora kinase 51 hematological cancers 51 Proleukin 51 CR# vcMMAE 51 Zalbin 51 adecatumumab 51 HSP# inhibitor 51 acute promyelocytic leukemia APL 51 tamoxifen therapy 51 denosumab 51 Camptosar 51 Cubicin 51 Epivir HBV 51 non metastatic osteosarcoma 51 eribulin mesylate 51 vinorelbine tartrate 51 Traficet EN 51 Tyverb 51 TroVax ® 51 Campath 51 QVA# 51 Peginterferon alfa 2b 51 metastatic renal cell 51 adjuvant 51 BRAF V# mutation 51 Pirfenidone 51 Telaprevir 51 Vidaza 51 aromatase inhibitor 51 ABX EGF 51 raltegravir 51 Aliskiren 51 TNF alpha inhibitors 51 liposomal doxorubicin 51 immunotherapeutic 51 menadione 51 trastuzumab 51 Revlimid 51 Privigen 51 vandetanib 51 Bayer Onyx 51 Elacytarabine 51 PROLARIS 51 Xcytrin 51 REOLYSIN ® 51 uric acid lowering 51 glufosfamide 51 pegfilgrastim 51 TriRima 51 irinotecan chemotherapy 51 chronic angina 51 interferon gamma 1b 51 SAR# [004] 51 BeneFIX 51 LUX Lung 51 CYT# potent vascular disrupting 51 Mycograb 51 Imprime PGG 51 palliative radiotherapy 51 ofatumumab 51 SinuNase 51 immunomodulators 51 leukotriene receptor antagonist 51 investigational monoclonal antibody 51 sulodexide 51 recurrent metastatic ovarian cancer 51 tesetaxel 51 topotecan 51 cetuximab Erbitux R 51 conjugated estrogen 51 targeting CD# 51 adult chronic ITP 51 Daclizumab 51 Alemtuzumab 51 Epoetin alfa 50 HyQ 50 G#DT 50 HGS ETR1 50 biliary tract cancer 50 Xinlay 50 Exenatide LAR 50 cytostatic 50 Advaxis Phase 50 RE LY 50 YERVOY 50 Rituxan 50 Millennium Velcade 50 raloxifene Evista 50 Horizant 50 Sutent 50 Cremophor 50 Iressa gefitinib 50 Hodgkin lymphoma HL 50 placebo controlled clinical 50 Mitoxantrone 50 abatacept 50 Edurant 50 gemcitabine Gemzar ® 50 idraparinux 50 canakinumab 50 Exemestane 50 paclitaxel poliglumex 50 Viibryd 50 Hectorol 50 Anastrozole 50 Fampyra 50 relapsing MS 50 Celebrex celecoxib 50 AVONEX 50 DCVax ® 50 Remodulin 50 taxane therapy 50 Certriad 50 Viramidine 50 Clofarabine 50 IMGN# 50 hepatocellular cancer 50 adjuvant colon cancer 50 Panitumumab 50 relapsed refractory multiple myeloma 50 Fareston 50 lenalidomide Revlimid R 50 carfilzomib 50 Camptosar ® 50 boosted protease inhibitor 50 Vaxfectin TM 50 Zactima 50 BENLYSTA 50 EGFR inhibitors 50 custirsen 50 Taxotere 50 omacetaxine 50 metastatic renal cell carcinoma 50 Clevudine 50 VEGF Trap 50 topical antimicrobial 50 nucleoside analogs 50 basiliximab 50 Orencia 50 severe hypercholesterolemia 50 convenient dosing regimens 50 anti angiogenic agent 50 Cellcept 50 Emend 50 afatinib 50 everolimus Afinitor 50 Istodax 50 Gemzar ® 50 Bayer Nexavar 50 Byetta LAR 50 histamine dihydrochloride 50 RoACTEMRA 50 Ozarelix 50 Bortezomib 50 decitabine 50 eflornithine 50 TASKi3 50 lurasidone 50 omalizumab 50 refractory AML 50 metastatic CRC 50 chronic lymphocytic leukemia CLL 50 Chemophase 50 prasugrel Effient 50 FOLFOX4 50 LHRH agonists 50 Taxol ® 50 Krystexxa 50 ACTEMRA TM 50 rBChE 50 Emselex 50 quinolone 50 PEGylated 50 EGFR mutation 50 cysteamine bitartrate 50 Pegasys peginterferon alfa 2a 50 mRCC 50 ocrelizumab 50 dacarbazine 50 zidovudine AZT 50 heavily pretreated 50 Sutent sunitinib malate 50 LBH# 50 visilizumab 50 hormone deprivation 50 eribulin 50 hematologic malignancies 50 HER2 positive cancers 50 non nucleoside 50 dasatinib 50 Novartis Afinitor 50 Hizentra 50 Zavesca 50 OPAXIO 50 anthracycline taxane 50 oral clodronate 50 Casodex 50 fluoropyrimidine 50 VIDAZA 50 TYKERB 50 Clolar 50 sorafenib 50 pancreatic adenocarcinoma 50 gemcitabine cisplatin 50 pancreatic neuroendocrine tumors 50 Esbriet 50 Alpharadin 50 AP# [003] 50 docetaxel 50 blood clot preventer 50 polymerase inhibitor 50 Eli Lilly Gemzar 50 TNF inhibitor 50 Ocrelizumab 50 blinatumomab 50 nilotinib 49 T#I [002] 49 advanced metastatic renal 49 angiogenesis inhibitors 49 Vaxfectin 49 idiopathic pulmonary fibrosis IPF 49 ImClone Erbitux 49 mycophenolate mofetil 49 Mabthera 49 Genasense 49 Arixtra 49 cisplatin chemotherapy 49 Kombiglyze XR 49 Tysabri natalizumab 49 Glaxo Tykerb 49 panobinostat 49 hA# 49 Interferon alpha 49 recurrent NSCLC 49 metoprolol succinate 49 infusional 5-FU/LV 49 dasatinib Sprycel ® 49 AVADO 49 Tekamlo 49 Tekturna HCT 49 Thalomid 49 gp# vaccine 49 Yondelis 49 factor G CSF 49 PROVENGE ® 49 Bicalutamide 49 DMARD 49 injectable formulation 49 Telintra 49 Gleevec resistant 49 ACZ# 49 eltrombopag 49 MVA BN R 49 TYGACIL 49 Intelence 49 Bexxar 49 TYZEKA 49 Cetuximab 49 estrogen receptor antagonist 49 cetuximab 49 metastatic CRPC 49 surrogate endpoint 49 IAP inhibitor 49 RG# [001] 49 voreloxin 49 plus gemcitabine 49 XELOX 49 Doxorubicin 49 Tavocept 49 carboplatin paclitaxel 49 ProSavin 49 Etoposide 49 immunosuppressant drug 49 Xifaxan 49 Glufosfamide 49 Tekturna aliskiren 49 refractory colorectal cancer 49 5-FU/LV 49 tipranavir 49 castrate resistant prostate cancer 49 immunomodulator 49 nitazoxanide 49 hormone refractory 49 metformin XR 49 brain metastases 49 chemotherapeutic regimens 49 microwave hyperthermia 49 entecavir 49 Entereg 49 vilazodone 49 TRILIPIX 49 temsirolimus Torisel ® 49 Novo Nordisk Victoza 49 PROSTVAC ® 49 CA4P 49 ozarelix 49 antibiotic Cubicin 49 Vorapaxar 49 somatostatin analogues 49 Rituximab 49 antibody fragment 49 Valopicitabine 49 IgG1 monoclonal antibody 49 Lialda 49 neuraminidase inhibitor 49 Immunogen 49 Noxafil 49 follicular NHL 49 refractory ovarian cancer 49 differentiated thyroid 49 SCCHN 49 gastrointestinal stromal tumors 49 AMN# [001] 49 Ceplene 49 refractory CLL 49 Asmanex 49 dacarbazine chemotherapy 49 telcagepant 49 Paraplatin ® 49 refractory multiple myeloma 49 betamethasone dipropionate 49 invasive candidiasis 49 Dificid 49 Adcirca 49 intravenously administered 49 TKI therapy 49 5 Fluorouracil